Otsuka Holdings
4578.T
#748
Rank
โ‚น2.873 T
Marketcap
โ‚น5,442
Share price
-0.19%
Change (1 day)
14.59%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2025 (TTM): โ‚น258.54

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is โ‚น278.95. In 2024 the company made an earnings per share (EPS) of โ‚น366.05 an increase over its 2023 EPS that were of โ‚น144.17.

EPS history for Otsuka Holdings from 2009 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น258.54-29.37%
2024โ‚น366.05153.9%
2023โ‚น144.17-15.71%
2022โ‚น171.04-6.18%
2021โ‚น182.30-24.1%
2020โ‚น240.1922.95%
2019โ‚น195.3556.13%
2018โ‚น125.12-25.11%
2017โ‚น167.0825.99%
2016โ‚น132.62-6.37%
2015โ‚น141.65
2014N/A-100%
2013โ‚น213.4218.06%
2012โ‚น180.771.01%
2011โ‚น178.9529.07%
2010โ‚น138.65-94.47%
2009โ‚น2,507